{"podcast":{"title":"Diabetes Insights - Breakthroughs and Innovators","slug":"diabetes-insights-breakthroughs-and-innovators-7109701","podcast_index_feed_id":7109701,"rss_url":"https://diabetes-insights.podigee.io/feed/mp3","website_url":"https://www.easd.org/","image_url":"https://images.podigee-cdn.net/0x,sD408c5FPq2zhlfDJcAkTWInzitsc0zqUqRLVfdBTdxE=/https://main.podigee-cdn.net/uploads/u69742/58c554e5-7dfd-4038-8798-07007c3176cf.jpg","author":"EASD - European Association for the Study of Diabetes","episode_count":74,"summary":"EASD presents: Diabetes Insights - Breakthroughs and Innovators Join us for expert interviews and discussions on the latest advances in diabetes research. Discover how groundbreaking medicines and cutting-edge technologies are shaping the future of diabetes treatment and management. Get inspired by the stories of distinguished researchers whose discoveries and contributions have transformed our understanding of diabetes. These podcasts were recorded at an EASD Annual Meeting. You can learn more about the research discussed by watching the scientific presentations in the EASD Media Centre (https://www.easd.org/media-centre/). New episode released every Friday.","last_synced_at":"2026-09-18T02:19:18.006264+00:00","page_url":"https://stenobird.com/podcast/diabetes-insights-breakthroughs-and-innovators-7109701"},"episode":{"title":"Dementia in Diabetes - Reasons for Hope or Concern?","slug":"dementia-in-diabetes-reasons-for-hope-or-concern","published_at":"2026-02-13T07:00:00+00:00","page_url":"https://stenobird.com/podcast/diabetes-insights-breakthroughs-and-innovators-7109701/dementia-in-diabetes-reasons-for-hope-or-concern","show_page_url":"https://stenobird.com/podcast/diabetes-insights-breakthroughs-and-innovators-7109701","url":"https://diabetes-insights.podigee.io/51-dementia-in-diabetes-reasons-for-hope-or-concern","audio_url":"https://audio.podigee-cdn.net/2350416-m-ec9ad6ceb413408c9b2447e65b9d9d35.mp3?source=feed","summary":"In this episode, Prof. Gill Livingston (University College London) and Prof. Thomas van Sloten (UMC Utrecht) explore the complex relationship between diabetes and dementia. People with diabetes face a higher risk of cognitive decline, particularly those with type 2 diabetes, and as treatment improves and life expectancy increases, dementia is becoming a growing clinical challenge. The discussion examines how diabetes medications, including GLP-1 receptor agonists and SGLT2 inhibitors, may influence cognitive outcomes, the role of lifestyle and vascular risk factors, and why prevention must become central to diabetes care. This episode also highlights the urgent need for clinical trials that include dementia and cognition as primary outcomes.","meta_description":"In this episode, Prof. Gill Livingston (University College London) and Prof. Thomas van Sloten (UMC Utrecht) explore the complex relationship between diab…","key_points":[],"chapters":[],"topics":[],"duration_seconds":758,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/diabetes-insights-breakthroughs-and-innovators-7109701/episodes/dementia-in-diabetes-reasons-for-hope-or-concern/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/diabetes-insights-breakthroughs-and-innovators-7109701/dementia-in-diabetes-reasons-for-hope-or-concern.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}